Westjtter, yes and quick response ...not many are left that remembered OxiGene
Now, if back in 2002 era Peregrine was able to utilize any new scientific findings from the collaboration...there are Biomarkers that are in play that also give Pererine, now Avid Bioservices CDMO that will be key.
Seems like so much more is going on also...that JP Morgan types don't want some to know ....though some new IIS will find out that buying CDMO in $7 range is true breadcrumbs ...so well worth the investment
I also noticed the ties to Moffitt ...and there are other places as well, that know the true value of the IP assets have yet to even be realized
I would strongly recommend that all read R66 posts from last week and forward any complaints to DOJ, because sometimes one may find out that some even in other Authorities "may" not have it in their interest to pursue open cases ...though with Moffitt new of Alan List and Thomas Sellers gone from Moffitt, I do believe PS Targeting and all other IP assets / Biomarkers will be known to others soon